Life technologies - lipofectamine rnaimax, 1.5ML 1.5ML aliquot - quote# P1035199
Ended Awarded
- Contract number
- HHSN31900002
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,300
Award facts
- Contract value 100% obligated
- $24,300.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from SAM.gov/FPDS.
About this award
Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a firm fixed price contract award from the National Center for Advancing Translational Sciences (NCATS) on March 11, 2014, for the supply of Lipofectamine RNAiMax reagent in 1.5 milliliter aliquots. This $24.3K contract, issued as a call against an existing Blanket Purchase Agreement (BPA) with no set-aside designation, reflects NCATS's procurement of specialized molecular biology reagents essential for translational science research. The performance location is Carlsbad, California, with an ultimate completion date of April 30, 2014. Lipofectamine RNAiMax is a transfection reagent commonly used in research settings to introduce RNA molecules into cells, supporting investigational work in genomics and molecular therapeutics.
The award exemplifies NCATS's reliance on established vendors within the federal supply chain for critical research consumables. Life Technologies Corporation, as a subsidiary of Thermo Electron Corporation, maintains significant federal contract vehicles across multiple agencies, including the National Institutes of Health and Department of Defense, and is recognized as a leading provider of scientific instruments, reagents, and analytical equipment. The BPA structure utilized for this procurement streamlines the agency's ability to access specialized biotechnology products on an as-needed basis, enabling efficient support of translational research initiatives aligned with NCATS's mission to advance biomedical innovation and accelerate the translation of scientific discoveries into practical applications.
Quick answers
Who was awarded contract HHSN31900002?
HHSN31900002 was awarded to Life Technologies Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on March 11, 2014.
How much is contract HHSN31900002 worth?
The government has obligated $24,300 on HHSN31900002.
Is contract HHSN31900002 an order under another contract?
Yes. HHSN31900002 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract HHSN31900002 competed?
The extent of competition for HHSN31900002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award